UPDATE – Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences

Rhea-AI Summary

Adaptive Biotechnologies Corporation (Nasdaq: ADPT) announced participation in two upcoming investor virtual conferences. The events include a Fireside Chat at the William Blair Virtual Growth Stock Conference on June 9 at 10 a.m. PT and a Fireside Chat at the Goldman Sachs Virtual Healthcare Conference on June 11 at 1:40 p.m. PT. Interested parties can access the live and archived webcasts on the company's website. Adaptive Biotechnologies focuses on developing clinical products utilizing the adaptive immune system for diagnosing and treating diseases.

SEATTLE, June 08, 2020 (GLOBE NEWSWIRE) -- This release was previously disseminated on May 27, 2020 at 16:03 ET. The date and time details for the conferences have been updated. The complete and corrected release follows.

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will participate in the following investor virtual conferences.

• William Blair Virtual Growth Stock Conference
  Fireside Chat on Tuesday, June 9^th at 10 a.m. Pacific Time / 12 p.m. Central Time
  
  
• Goldman Sachs Virtual Healthcare Conference
  Fireside Chat on Thursday, June 11^th at 1:40 p.m. Pacific Time / 4:40 p.m. Eastern Time
  

Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.adaptivebiotech.com.

About Adaptive Biotechnologies

Adaptive Biotechnologies is a commercial-stage biotech company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature’s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed to develop products in life sciences research, clinical diagnostics, and drug discovery. We have two commercial products, and a robust clinical pipeline to diagnose, monitor and enable the treatment of diseases such as cancer, autoimmune conditions and infectious diseases. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient. For more information, please visit adaptivebiotech.com and follow us on www.twitter.com/adaptivebiotech.       

Investor Contact:
Karina Calzadilla, Vice President, Investor Relations
Carrie Mendivil, Gilmartin Group
investors@adaptivebiotech.com

Media Contact:
Beth Keshishian
media@adaptivebiotech.com

FAQ

When is Adaptive Biotechnologies participating in the William Blair Virtual Growth Stock Conference?

Adaptive Biotechnologies will participate in the William Blair Virtual Growth Stock Conference on June 9 at 10 a.m. PT.

What time is the Goldman Sachs Virtual Healthcare Conference for Adaptive Biotechnologies?

The Goldman Sachs Virtual Healthcare Conference for Adaptive Biotechnologies is scheduled for June 11 at 1:40 p.m. PT.

Where can I access the webcasts for the Adaptive Biotechnologies conferences?

You can access the live and archived webcasts for Adaptive Biotechnologies' conferences on their official website under the 'Investors' section.

What does Adaptive Biotechnologies do?

Adaptive Biotechnologies focuses on using the adaptive immune system to create clinical products for disease diagnosis and treatment.